2019
Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools
Foldi J, O'Meara T, Marczyk M, Sanft T, Silber A, Pusztai L. Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools. Journal Of Clinical Oncology 2019, 37: jco.18.01933. PMID: 30943126, DOI: 10.1200/jco.18.01933.Peer-Reviewed Original Research
2017
Serum lipid profile discriminates patients with early lung cancer from healthy controls
Ros-Mazurczyk M, Jelonek K, Marczyk M, Binczyk F, Pietrowska M, Polanska J, Dziadziuszko R, Jassem J, Rzyman W, Widlak P. Serum lipid profile discriminates patients with early lung cancer from healthy controls. Lung Cancer 2017, 112: 69-74. PMID: 29191603, DOI: 10.1016/j.lungcan.2017.07.036.Peer-Reviewed Original ResearchConceptsEarly lung cancerSerum lipid profileLung cancerNegative predictive valuePredictive valueCancer patientsLipid profileComputed tomography lung cancer screeningLow-dose computed tomography (LDCT) lung cancer screeningTomography lung cancer screeningEarly-stage lung cancerHealthy participantsEarly lung cancer patientsLow-dose computed tomographyHigh-risk smokersLung cancer screeningLung cancer patientsStage lung cancerMaximum negative predictive valueBlood-based biomarkersPositive predictive valueSerum lipidomeCancer screeningHealthy controlsSerum signature